NSEAcquisition3d ago · 2 Sept 2026, 04:11 pm
Acquisition
Indo-National Limited · NIPPOBATRY
✦ AI SummaryM&A
Indo-National Limited has informed the Exchange about acquiring an additional 0.78% stake in Medcuore Medical Solutions Private Ltd for Rs. 50,03,864, taking its total shareholding to 61.87%. The acquisition is not a related party transaction and is expected to facilitate business growth and generate revenue.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indo-National Limited has informed the Exchange about Acquisition
Attachments (1)
📄pdf
Download →
NIPPOBATRY_02092026161114_INL_Stock_Exchange_Disclosuresd.pdf
View document text
2nd September 2026
BSE Limited
National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers,
"Exchange Plaza", 5th Floor,
Dalal Street, Fort,
Plot No. C/1, G Block Bandra-Kurla Complex
Mumbai 400 001
Bandra (East), Mumbai 400 051
Scrip code: 504058
NSE SYMBOL: NIPPOBATRY
Dear Sir/Madam,
Sub: Intimation under Regulation 30 read with Schedule III of Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
(“SEBI LODR”), as amended read with the Securities and Exchange Board of India
(“SEBI”) master circular dated November 11, 2024, bearing reference no.
SEBI/HO/CFD/PoD2/CIR/P/0155 (“SEBI Circular”)
Pursuant to the provisions of Regulation 30 of the SEBI LODR, we would like to inform that
the Company has invested an aggregate amount of Rs. 50,03,864 (Rupees Fifty Lakh Three
Thousand Eight Hundred and Sixty-Four only), by way of subscription to Equity Shares of
Medcuore Medical Solutions Private Ltd (“MMSPL”).
The said investment represents an additional 0.78% of the paid-up share capital in MMSPL on
a fully diluted basis.
The disclosure required under Schedule III of the SEBI LODR read with the SEBI Circular, is
enclosed herewith as Annexure-A.
Kindly take the above on your record.
For Indo National Limited
J. Srinivasan
Company Secretary
lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034.
Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006.
CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in
ANNEXURE – A
Disclosure of information as required under SEBI circular are as follows:-
Particulars Details
1. n ame of the target entity, details in Name: Medcuore Medical Solutions Private Ltd
brief such as size, turnover etc.;
Turnover (FY 25-26): Rs. 1,45,60,000
2. w hether the acquisition would fall Pursuant to an additional primary investment of Rs.
within related party transaction(s) 50,03,864, the Company has acquired a further 0.78%
and whether the promoter/ equity stake in MMSPL. Following this acquisition, the
promoter group/ group companies Company’s aggregate shareholding in MMSPL now stands
have any interest in the entity being at 61.87%. The acquisition would not fall under related
acquired? If yes, nature of interest party transaction. None of the promoter/ promoter group/
and details thereof and whether the group companies have any interest in the entity being
same is done at “arm’s length” acquired.
3. I ndustry to which the entity being MMSPL is engaged in the business of manufacturing,
acquired belongs distribution and providing services in relation to Air
Monitoring System and Air Purifiers.
4. o bjects and impact of acquisition Object and impact: To facilitate business growth and to
(including but not limited to, generate revenue and to earn profit due to expansion of
disclosure of reasons for acquisition business
of target entity, if its business is
outside the main line of business of
the listed entity);
5. b rief details of any governmental or Nil
regulatory approvals required for
the acquisition;
6. I ndicative time period for Upto FY 2027-28
completion of the acquisition
7. C onsideration- whether cash Cash consideration
consideration or share swap or any
other form and details of the same.
lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034.
Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006.
CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in
Particulars Details
8. C ost of acquisition and/or the price 153 shares were acquired based on valuation report issued
at which the shares are acquired; by registered valuer dated May 16, 2026. The price per
share is Rs. 16,536/- (Rupees Sixteen thousand five hundred
and thirty six).
176 shares were acquired based on valuation report issued
by registered valuer dated August 21, 2026. The price per
share is Rs. 14,056/- (Rupees Fourteen Thousand and Fifty
Six).
9. P ercentage of shareholding / An additional 0.78% of the paid-up share capital in MMSPL
control acquired and / or number of has been acquired, taking the Company’s total shareholding
shares acquired to 61.87%.
Number of shares acquired: 329 shares
10. B rief background about the entity a. Name: Medcuore Medical Solutions Private Ltd
acquired in terms of products/line
of business acquired, date of b. Product and Line of Business: business of manufacturing,
incorporation, history of last 3 years distribution and providing services in relation to Air
turnover, country in which the Monitoring System and Air Purifiers.
acquired entity has presence and
c. Date of Incorporation: 07/06/2020
any other significant information (in
brief)
d. Last 3 years turnover:
FY 26 Rs. 1,45,60,000
FY 25 Rs. 35,41,484
FY24 Rs. 47,68,000
e. country in which the acquired entity has presence: India
lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034.
Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006.
CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in